Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients

M. N. Al-Hasan, Raymund R Razonable, Jeanette E Eckel-Passow, L. M. Baddour

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Bacterial infections are common complications of solid organ transplantation (SOT). In this study, we defined the incidence, mortality and in vitro antimicrobial resistance rates of Gram-negative bloodstream infection (BSI) in SOT recipients. We identified 223 patients who developed Gram-negative BSI among a cohort of 3367 SOT recipients who were prospectively followed at the Mayo Clinic (Rochester, MN) from January 1, 1996 to December 31, 2007. The highest incidence rate (IR) of Gram-negative BSI was observed within the first month following SOT (210.3/1000 person-years [95% confidence interval (CI): 159.3-268.3]), with a sharp decline to 25.7 (95% CI: 20.1-32.1) and 8.2 (95% CI: 6.7-10.0) per 1000 person-years between 2 and 12 months and more than 12 months following SOT, respectively. Kidney recipients were more likely to develop Gram-negative BSI after 12 months following transplantation than were liver recipients (10.3 [95% CI: 7.9-13.1] vs. 5.2 [95% CI: 3.1-7.8] per 1000 person-years). The overall unadjusted 28-day all-cause mortality of Gram-negative BSI was 4.9% and was lower in kidney than in liver recipients (1.6% vs. 13.2%, p < 0.001). We observed a linear trend of increasing resistance among Escherichia coli isolates to fluoroquinolone antibiotics from 0% to 44% (p = 0.002) throughout the study period. This increase in antimicrobial resistance may influence the choice of empiric therapy.

Original languageEnglish (US)
Pages (from-to)835-843
Number of pages9
JournalAmerican Journal of Transplantation
Volume9
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Organ Transplantation
Confidence Intervals
Transplants
Incidence
Infection
Kidney
Mortality
Fluoroquinolones
Bacterial Infections
Liver Transplantation
Transplant Recipients
Escherichia coli
Anti-Bacterial Agents
Liver

Keywords

  • Antibiotic resistance
  • Bloodstream infection
  • Epidemiology
  • Mortality
  • Solid organ transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. / Al-Hasan, M. N.; Razonable, Raymund R; Eckel-Passow, Jeanette E; Baddour, L. M.

In: American Journal of Transplantation, Vol. 9, No. 4, 04.2009, p. 835-843.

Research output: Contribution to journalArticle

@article{e7a03ea503554666b3819e5a0355fc29,
title = "Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients",
abstract = "Bacterial infections are common complications of solid organ transplantation (SOT). In this study, we defined the incidence, mortality and in vitro antimicrobial resistance rates of Gram-negative bloodstream infection (BSI) in SOT recipients. We identified 223 patients who developed Gram-negative BSI among a cohort of 3367 SOT recipients who were prospectively followed at the Mayo Clinic (Rochester, MN) from January 1, 1996 to December 31, 2007. The highest incidence rate (IR) of Gram-negative BSI was observed within the first month following SOT (210.3/1000 person-years [95{\%} confidence interval (CI): 159.3-268.3]), with a sharp decline to 25.7 (95{\%} CI: 20.1-32.1) and 8.2 (95{\%} CI: 6.7-10.0) per 1000 person-years between 2 and 12 months and more than 12 months following SOT, respectively. Kidney recipients were more likely to develop Gram-negative BSI after 12 months following transplantation than were liver recipients (10.3 [95{\%} CI: 7.9-13.1] vs. 5.2 [95{\%} CI: 3.1-7.8] per 1000 person-years). The overall unadjusted 28-day all-cause mortality of Gram-negative BSI was 4.9{\%} and was lower in kidney than in liver recipients (1.6{\%} vs. 13.2{\%}, p < 0.001). We observed a linear trend of increasing resistance among Escherichia coli isolates to fluoroquinolone antibiotics from 0{\%} to 44{\%} (p = 0.002) throughout the study period. This increase in antimicrobial resistance may influence the choice of empiric therapy.",
keywords = "Antibiotic resistance, Bloodstream infection, Epidemiology, Mortality, Solid organ transplantation",
author = "Al-Hasan, {M. N.} and Razonable, {Raymund R} and Eckel-Passow, {Jeanette E} and Baddour, {L. M.}",
year = "2009",
month = "4",
doi = "10.1111/j.1600-6143.2009.02559.x",
language = "English (US)",
volume = "9",
pages = "835--843",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients

AU - Al-Hasan, M. N.

AU - Razonable, Raymund R

AU - Eckel-Passow, Jeanette E

AU - Baddour, L. M.

PY - 2009/4

Y1 - 2009/4

N2 - Bacterial infections are common complications of solid organ transplantation (SOT). In this study, we defined the incidence, mortality and in vitro antimicrobial resistance rates of Gram-negative bloodstream infection (BSI) in SOT recipients. We identified 223 patients who developed Gram-negative BSI among a cohort of 3367 SOT recipients who were prospectively followed at the Mayo Clinic (Rochester, MN) from January 1, 1996 to December 31, 2007. The highest incidence rate (IR) of Gram-negative BSI was observed within the first month following SOT (210.3/1000 person-years [95% confidence interval (CI): 159.3-268.3]), with a sharp decline to 25.7 (95% CI: 20.1-32.1) and 8.2 (95% CI: 6.7-10.0) per 1000 person-years between 2 and 12 months and more than 12 months following SOT, respectively. Kidney recipients were more likely to develop Gram-negative BSI after 12 months following transplantation than were liver recipients (10.3 [95% CI: 7.9-13.1] vs. 5.2 [95% CI: 3.1-7.8] per 1000 person-years). The overall unadjusted 28-day all-cause mortality of Gram-negative BSI was 4.9% and was lower in kidney than in liver recipients (1.6% vs. 13.2%, p < 0.001). We observed a linear trend of increasing resistance among Escherichia coli isolates to fluoroquinolone antibiotics from 0% to 44% (p = 0.002) throughout the study period. This increase in antimicrobial resistance may influence the choice of empiric therapy.

AB - Bacterial infections are common complications of solid organ transplantation (SOT). In this study, we defined the incidence, mortality and in vitro antimicrobial resistance rates of Gram-negative bloodstream infection (BSI) in SOT recipients. We identified 223 patients who developed Gram-negative BSI among a cohort of 3367 SOT recipients who were prospectively followed at the Mayo Clinic (Rochester, MN) from January 1, 1996 to December 31, 2007. The highest incidence rate (IR) of Gram-negative BSI was observed within the first month following SOT (210.3/1000 person-years [95% confidence interval (CI): 159.3-268.3]), with a sharp decline to 25.7 (95% CI: 20.1-32.1) and 8.2 (95% CI: 6.7-10.0) per 1000 person-years between 2 and 12 months and more than 12 months following SOT, respectively. Kidney recipients were more likely to develop Gram-negative BSI after 12 months following transplantation than were liver recipients (10.3 [95% CI: 7.9-13.1] vs. 5.2 [95% CI: 3.1-7.8] per 1000 person-years). The overall unadjusted 28-day all-cause mortality of Gram-negative BSI was 4.9% and was lower in kidney than in liver recipients (1.6% vs. 13.2%, p < 0.001). We observed a linear trend of increasing resistance among Escherichia coli isolates to fluoroquinolone antibiotics from 0% to 44% (p = 0.002) throughout the study period. This increase in antimicrobial resistance may influence the choice of empiric therapy.

KW - Antibiotic resistance

KW - Bloodstream infection

KW - Epidemiology

KW - Mortality

KW - Solid organ transplantation

UR - http://www.scopus.com/inward/record.url?scp=63349093065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63349093065&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2009.02559.x

DO - 10.1111/j.1600-6143.2009.02559.x

M3 - Article

C2 - 19344469

AN - SCOPUS:63349093065

VL - 9

SP - 835

EP - 843

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 4

ER -